5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine

C79H71Cl3F5N23O — CID 170430292

IUPAC5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
SMILESCN1C(=O)C(F)(F)c2c1ccc(-c1[nH]nc3nc(N4CC[C@@H]5[C@H](C4)[C@@]5(CN)c4ccccc4F)cnc13)c2Cl.Cn1cc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c2n1.Cn1ncc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c21
InChIInChI=1S/C27H23ClF3N7O.2C26H24ClFN8/c1-37-18-7-6-13(21(28)20(18)27(30,31)25(37)39)22-23-24(36-35-22)34-19(10-33-23)38-9-8-14-16(11-38)26(14,12-32)15-4-2-3-5-17(15)29;1-35-11-14-6-7-15(21(27)22(14)34-35)23-24-25(33-32-23)31-20(10-30-24)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28;1-35-24-14(10-31-35)6-7-15(21(24)27)22-23-25(34-33-22)32-20(11-30-23)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28/h2-7,10,14,16H,8-9,11-12,32H2,1H3,(H,34,35,36);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,31,32,33);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,32,33,34)/t14-,16+,26-;2*16-,18+,26-/m111/s1
InChIKeyNLACGGKARYESBM-ODZVRZJHSA-N
MW1559.95 g/mol
LogP12.34
Rot. Bonds12

About 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine

5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine (PubChem CID 170430292) has the molecular formula C79H71Cl3F5N23O and a molecular weight of 1559.95 g/mol. Its IUPAC name is 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine.

Molecular Properties

Compound Name5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
PubChem CID170430292
Molecular FormulaC79H71Cl3F5N23O
Molecular Weight1559.95 g/mol
Exact Mass1557.52
IUPAC Name5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine
SMILESCN1C(=O)C(F)(F)c2c1ccc(-c1[nH]nc3nc(N4CC[C@@H]5[C@H](C4)[C@@]5(CN)c4ccccc4F)cnc13)c2Cl.Cn1cc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c2n1.Cn1ncc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c21
InChIInChI=1S/C27H23ClF3N7O.2C26H24ClFN8/c1-37-18-7-6-13(21(28)20(18)27(30,31)25(37)39)22-23-24(36-35-22)34-19(10-33-23)38-9-8-14-16(11-38)26(14,12-32)15-4-2-3-5-17(15)29;1-35-11-14-6-7-15(21(27)22(14)34-35)23-24-25(33-32-23)31-20(10-30-24)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28;1-35-24-14(10-31-35)6-7-15(21(24)27)22-23-25(34-33-22)32-20(11-30-23)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28/h2-7,10,14,16H,8-9,11-12,32H2,1H3,(H,34,35,36);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,31,32,33);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,32,33,34)/t14-,16+,26-;2*16-,18+,26-/m111/s1
InChIKeyNLACGGKARYESBM-ODZVRZJHSA-N
XLogP12.34
TPSA307.11 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds12
Heavy Atoms111
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001559.95
LogP ≤ 512.34
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Analyze 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The IUPAC name of 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine (CID 170430292) is 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine.
What is the SMILES notation for 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The canonical SMILES for 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine is CN1C(=O)C(F)(F)c2c1ccc(-c1[nH]nc3nc(N4CC[C@@H]5[C@H](C4)[C@@]5(CN)c4ccccc4F)cnc13)c2Cl.Cn1cc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c2n1.Cn1ncc2ccc(-c3[nH]nc4nc(N5CC[C@@H]6[C@H](C5)[C@@]6(CN)c5ccccc5F)cnc34)c(Cl)c21.
What is the InChIKey of 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
The InChIKey is NLACGGKARYESBM-ODZVRZJHSA-N. The full InChI is InChI=1S/C27H23ClF3N7O.2C26H24ClFN8/c1-37-18-7-6-13(21(28)20(18)27(30,31)25(37)39)22-23-24(36-35-22)34-19(10-33-23)38-9-8-14-16(11-38)26(14,12-32)15-4-2-3-5-17(15)29;1-35-11-14-6-7-15(21(27)22(14)34-35)23-24-25(33-32-23)31-20(10-30-24)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28;1-35-24-14(10-31-35)6-7-15(21(24)27)22-23-25(34-33-22)32-20(11-30-23)36-9-8-16-18(12-36)26(16,13-29)17-4-2-3-5-19(17)28/h2-7,10,14,16H,8-9,11-12,32H2,1H3,(H,34,35,36);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,31,32,33);2-7,10-11,16,18H,8-9,12-13,29H2,1H3,(H,32,33,34)/t14-,16+,26-;2*16-,18+,26-/m111/s1.
What are the key properties of 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine?
5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine has a molecular weight of 1559.95 g/mol, XLogP of 12.34, 12 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[6-[(1S,6R,7R)-7-(aminomethyl)-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-3-yl]-2H-pyrazolo[3,4-b]pyrazin-3-yl]-4-chloro-3,3-difluoro-1-methylindol-2-one;[(1S,6R,7R)-3-[3-(7-chloro-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine;[(1S,6R,7R)-3-[3-(7-chloro-2-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-7-(2-fluorophenyl)-3-azabicyclo[4.1.0]heptan-7-yl]methanamine is sourced from PubChem (CID 170430292), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).